Recombinant Rat Long-chain-fatty-acid--CoA ligase 1 (Acsl1)

What expression systems are available for recombinant Acsl1 production?

Recombinant Acsl1 can be expressed in several systems, each offering distinct advantages depending on research requirements. The most common expression systems include:

Yeast expression systems provide good protein yield with proper eukaryotic post-translational modifications for rat Acsl1 (AA 46-699) . This system is particularly useful when studying enzymatic activity that may depend on proper protein folding. E. coli expression systems offer high yield and cost-effectiveness for producing full-length rat Acsl1 (1-699aa) with N-terminal His tags . This bacterial system is ideal for structural studies and applications requiring larger protein quantities.

Mammalian expression systems, particularly HEK-293 cells, can be utilized for both human and mouse Acsl1 expression with greater than 90% purity . These systems provide the most native-like post-translational modifications but at higher cost and lower yield compared to microbial systems. When selecting an expression system, researchers should consider the specific downstream applications, required protein purity, and whether post-translational modifications are critical to their experimental design.

For protein characterization studies, researchers should note that differences in expression systems may lead to variations in enzyme activity profiles. If you are interested in expressing Acsl1 in alternative systems like baculovirus infection, be aware that differences in price and production time should be factored into experimental planning .

What purification and validation methods are appropriate for recombinant Acsl1?

Effective purification and validation of recombinant Acsl1 requires a multi-step approach to ensure protein quality and functionality:

Affinity chromatography using His-tag capture represents the primary purification method for recombinant Acsl1, yielding protein purity typically greater than 90% as determined by SDS-PAGE . The His-tagged Acsl1 protein allows for single-step purification using nickel or cobalt resin columns, which is particularly efficient for rat Acsl1 proteins expressed in both yeast and E. coli systems .

Validation methods should include SDS-PAGE to confirm molecular weight and purity . For more precise characterization, analytical SEC (HPLC) can be employed, especially for human Acsl1 expressed in HEK-293 cells . Enzyme activity assays measuring the conversion of long-chain fatty acids to their CoA derivatives provide functional validation, which is critical when studying the kinetic properties of Acsl1.

Western blot analysis using anti-His antibodies or specific anti-Acsl1 antibodies confirms protein identity . For recombinant Acsl1 intended for immunological studies, ELISA validation ensures the protein maintains proper epitope presentation . Researchers should also consider sequence verification to confirm the integrity of the expressed protein, particularly when studying structure-function relationships of the 699-amino acid sequence provided in the product specifications .

What are the optimal storage and handling conditions for recombinant Acsl1?

Proper storage and handling of recombinant Acsl1 is critical for maintaining protein stability and enzymatic activity:

For long-term storage, recombinant Acsl1 is typically supplied as a lyophilized powder that should be stored at -20°C to -80°C immediately upon receipt . Aliquoting is necessary for multiple use to avoid repeated freeze-thaw cycles that can significantly degrade protein structure and activity . When reconstituting lyophilized Acsl1, researchers should use deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL .

The addition of glycerol to a final concentration of 5-50% (optimally 50%) is recommended when preparing aliquots for long-term storage at -20°C/-80°C . This prevents ice crystal formation that can damage protein structure. For working aliquots, storage at 4°C is recommended, but only for up to one week to maintain protein integrity .

The reconstitution buffer typically consists of Tris/PBS-based buffer with 6% Trehalose at pH 8.0, which helps maintain protein stability . It is advisable to briefly centrifuge the protein vial before opening to ensure all content is at the bottom of the tube . Researchers should minimize exposure to repeated freeze-thaw cycles as this significantly reduces protein activity and structural integrity. For experiments requiring maximum enzymatic activity, freshly thawed aliquots should be used whenever possible.

What are the tissue-specific functions of Acsl1 relevant to experimental design?

Understanding the tissue-specific functions of Acsl1 is crucial when designing experiments investigating its metabolic and immunological roles:

In liver tissue, Acsl1 serves as the main ACSL family member expressed and plays critical roles in triacylglycerol (TAG) synthesis and fatty acid oxidation . Liver-specific knockout studies have demonstrated reduced TAG synthesis and fatty acid oxidation, highlighting Acsl1's central role in hepatic lipid metabolism . This makes liver-derived experimental models particularly valuable for studying the fundamental mechanisms of Acsl1 in lipid processing.

In adipose tissue, Acsl1 is specifically required for fatty acid beta-oxidation and has been associated with increased lipid content and insulin sensitivity in human adipocytes . Interestingly, Acsl1 knockdown in adipocytes results in the upregulation of proinflammatory markers including CCL2, CCL5, and CD14, suggesting an important immunomodulatory role . When designing adipose tissue experiments, researchers should consider these dual metabolic and inflammatory functions.

In skeletal muscle, Acsl1 is specifically required for fatty acid beta-oxidation, similar to its role in adipose tissue . This tissue-specific function should be considered when designing muscle metabolism studies. Acsl1 is also highly expressed in prostate tissue and blood, with the latter suggesting its prominent role in immunity compared to other ACSL family members .

Experimental designs should account for these tissue-specific functions, particularly when using tissue-specific knockdown or knockout models. The differential expression and function across tissues provide opportunities for targeted manipulation in research contexts focused on metabolism, inflammation, or tissue-specific disease models.

How can gene knockdown approaches be optimized to study Acsl1 function?

Adenovirus-mediated gene knockdown (KD) represents a powerful approach for studying the acute effects of hepatic Acsl1 deficiency on fatty acid metabolism:

The optimization of adenoviral vectors carrying short hairpin RNA (shRNA) against Acsl1 (Ad-shAcsl1) provides an effective means for acute knockdown in liver tissue . Compared to traditional knockout models, this approach allows for the examination of immediate metabolic consequences before compensatory mechanisms can fully develop. When designing knockdown experiments, researchers should include appropriate controls such as adenoviral vectors carrying non-targeting shRNA (Ad-shU6-C) to account for potential effects of viral infection .

For transcriptomic analysis following Acsl1 knockdown, microarray hybridization using platforms such as Mouse Gene 2.0 ST can provide comprehensive insights into downstream gene expression changes . Data normalization using Robust Multiarray Average (RMA) implementation in packages like "affy" (version 1.36.1) is recommended for generating reliable gene-level expression values . Statistical analysis should employ moderated t-tests, such as those implemented in the "limma" package (version 3.14.4), with correction for multiple hypothesis testing using the Benjamini-Hochberg false discovery rate (FDR) .

When interpreting results, consider biologically significant changes as those with at least 1.5-fold change and P-value < 0.05 . This threshold balances sensitivity and specificity in identifying relevant gene expression changes. For liver-specific studies in models of metabolic disease, high-fat diet (HFD) feeding prior to Acsl1 knockdown can provide valuable insights into the role of this enzyme in diet-induced metabolic alterations .

What are the methodological approaches for studying Acsl1 in inflammation and immunity?

Acsl1's emerging role in inflammation and immunity necessitates specialized methodological approaches:

In macrophage-focused studies, researchers should consider the increased expression of Acsl1 observed in response to various inflammatory stimuli, including mycobacterium tuberculosis infection, Gram-negative bacteria, lipopolysaccharide (LPS), and Toll-like receptor agonists . These stimuli provide experimental models for studying how Acsl1 expression changes during inflammatory conditions and the consequent effects on lipid metabolism.

To investigate the specific role of Acsl1 in arachidonic acid metabolism in macrophages, researchers can employ Acsl1-deficient macrophage models, which have shown marked reduction in arachidonoyl-CoA levels without impairment in beta-oxidation or lipid accumulation . This suggests a specific role for Acsl1 in handling arachidonic acid, a critical precursor for inflammatory eicosanoids.

For studying the connection between Acsl1 and inflammation in adipose tissue, knockdown approaches have revealed upregulation of proinflammatory chemokines (CCL2, CCL5) and macrophage-associated surface antigens (CD14) . This provides a methodological framework for examining how lipid metabolism enzymes like Acsl1 influence inflammatory signaling pathways.

The relationship between Acsl1 and NFκB signaling can be investigated using inhibitors like aspirin, which has been shown to down-regulate Acsl1 expression in liver cancer cells through inhibition of NFκB-ACSL1 signaling . This approach offers insights into the regulatory mechanisms controlling Acsl1 expression during inflammation.

When designing experiments to study Acsl1 in immune cells, researchers should note its particularly high expression in blood compared to other ACSL family members, suggesting a more prominent role in immunity . This observation should guide tissue and cell type selection for immunological studies involving Acsl1.

How does Acsl1 contribute to disease pathogenesis in metabolic and inflammatory conditions?

Acsl1's involvement in various pathological conditions provides important research opportunities:

In diabetes models, increased expression of Acsl1 has been observed in monocytes and macrophages from patients with type 1 diabetes . Research methodologies should include comparative expression analysis between diabetic and non-diabetic samples, with attention to inflammatory phenotypes that correlate with Acsl1 abundance . In macrophages from diabetic mouse models, Acsl1 deficiency leads to reduced arachidonoyl-CoA levels without affecting beta-oxidation or lipid accumulation, suggesting specific experimental approaches focused on arachidonic acid metabolism rather than general lipid processing .

For cancer research, upregulation of Acsl1 has been documented in various cancer types including breast, colon, and liver cancer . Experimental designs should incorporate analysis of Acsl1 expression in tumor versus normal tissue, with potential therapeutic implications through Acsl1 inhibition. The finding that aspirin down-regulates Acsl1 expression in liver cancer cells through inhibition of NFκB-ACSL1 signaling suggests experimental approaches using anti-inflammatory drugs to modulate Acsl1 expression .

In infection models, human PBMC-derived macrophages infected with mycobacterium tuberculosis demonstrate increased Acsl1 expression and enhanced lipid droplet formation . This provides an experimental framework for studying how pathogens may exploit host lipid metabolism enzymes for their survival and replication.

When designing studies on inflammatory conditions, consider that Gram-negative bacteria and LPS induce Acsl1 expression, correlating with increased phospholipid turnover . Similarly, Toll-like receptor agonists promote prolonged triglyceride retention associated with increased Acsl1 expression . These observations suggest experimental approaches using various inflammatory stimuli to study Acsl1 regulation and function.

What analytical techniques are optimal for studying Acsl1-mediated metabolic changes?

Advanced analytical techniques are essential for comprehensive characterization of Acsl1-mediated metabolic alterations:

For transcriptomic analysis, microarray technology using platforms such as Mouse Gene 2.0 ST with Robust Multiarray Average (RMA) normalization provides comprehensive gene expression profiles . When analyzing differential expression between experimental groups (e.g., Acsl1 knockdown versus control), moderated t-tests with Benjamini-Hochberg false discovery rate correction are recommended statistical approaches . Setting thresholds of 1.5-fold change and P-value < 0.05 identifies biologically significant gene expression changes resulting from Acsl1 manipulation .

Lipidomic analysis should be employed to characterize changes in fatty acid activation and subsequent metabolic fates. Given Acsl1's highest substrate specificity for saturated and monounsaturated fatty acids with 16-18 carbon length, analytical methods should be optimized for these lipid species . In hepatocytes, overexpression of Acsl1 increases oleate incorporation into diacylglycerol and phospholipids, suggesting targeted analysis of these lipid classes .

For macrophage-specific studies, analysis of arachidonoyl-CoA levels is particularly important given the observed reduction in these metabolites in Acsl1-deficient macrophages from diabetic mouse models . This requires sensitive analytical techniques capable of detecting specific acyl-CoA species.

When studying the relationship between Acsl1 and fatty acid uptake, analytical approaches should consider the "metabolic trapping" mechanism proposed in adipocytes and human hepatoma cells . This requires techniques that can distinguish between uptake, activation, and subsequent metabolic utilization of fatty acids.

For tissue-specific studies, analytical methods should be tailored to the predominant metabolic pathways affected by Acsl1 in each tissue. In liver, focus should be on TAG synthesis and fatty acid oxidation; in adipose tissue and muscle, emphasis should be on beta-oxidation; and in inflammatory cells, attention should be given to arachidonic acid metabolism and inflammatory mediator production .